ah

AdaptHealth

AHCO
NASDAQ
$5.87

Is AdaptHealth financially strong?

After the April 2026 refinancing, AdaptHealth entered a 2026 Credit Facility (term loan + delayed‑draw term loan + $450M revolver) and in August 2026 redeemed its 6.125% notes due 2028 using the delayed‑draw term loan.

As of June 30, 2026: secured term loan $325M, revolver $150M, senior unsecured notes $1.425B (4.625% due 2029; 5.125% due 2030), cash ~$43M; pro forma for the redemption, fixed‑rate notes are staggered into 2029/2030 and the bank debt matures in 2031 (with springing maturities tied to note balances).

Leverage and interest burden remain material, leaving limited cushion if EBITDA underperforms.